HOTH vs MS · rev $1.24B vs P/E 20, $344.27B cap
Hoth Therapeutics Inc (HOTH) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
MS does not have a complete income-statement cache yet.
HOTH currently screens at market cap $15.5M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the HOTH and MS stock pages for the full models.
Not investment advice.